These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 8633588

  • 1. Helicobacter pylori infection is the major risk factor for atrophic gastritis.
    Kawaguchi H, Haruma K, Komoto K, Yoshihara M, Sumii K, Kajiyama G.
    Am J Gastroenterol; 1996 May; 91(5):959-62. PubMed ID: 8633588
    [Abstract] [Full Text] [Related]

  • 2. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
    Ohkusa T, Miwa H, Nomura T, Asaoka D, Kurosawa A, Sakamoto N, Abe S, Hojo M, Terai T, Ogihara T, Sato N.
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
    [Abstract] [Full Text] [Related]

  • 3. Chronic atrophic gastritis and Helicobacter pylori infection in primary biliary cirrhosis: a cross-sectional study with matching.
    Floreani A, Biagini MR, Zappalà F, Farinati F, Plebani M, Rugge M, Surrenti C, Naccarato R.
    Ital J Gastroenterol Hepatol; 1997 Feb; 29(1):13-7. PubMed ID: 9265572
    [Abstract] [Full Text] [Related]

  • 4. [Dynamic monitoring of serum pepsinogen among high risk populations of gastric cancer in Zhuanghe county].
    Sun LP, Gong YH, Wang L, Gong W, Yuan Y.
    Zhonghua Yi Xue Za Zhi; 2006 Oct 31; 86(40):2826-30. PubMed ID: 17200016
    [Abstract] [Full Text] [Related]

  • 5. Pernicious anemia and Helicobacter pylori infection in Japan: evaluation in a country with a high prevalence of infection.
    Haruma K, Komoto K, Kawaguchi H, Okamoto S, Yoshihara M, Sumii K, Kajiyama G.
    Am J Gastroenterol; 1995 Jul 31; 90(7):1107-10. PubMed ID: 7611206
    [Abstract] [Full Text] [Related]

  • 6. Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status.
    Sozzi M, Valentini M, Figura N, De Paoli P, Tedeschi RM, Gloghini A, Serraino D, Poletti M, Carbone A.
    Am J Gastroenterol; 1998 Mar 31; 93(3):375-9. PubMed ID: 9517643
    [Abstract] [Full Text] [Related]

  • 7. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
    Cao Q, Ran ZH, Xiao SD.
    J Dig Dis; 2007 Feb 31; 8(1):15-22. PubMed ID: 17261130
    [Abstract] [Full Text] [Related]

  • 8. Prevalence of H. pylori infection and atrophic gastritis among symptomatic and dyspeptic adults in Kazakhstan. A hospital-based screening study using a panel of serum biomarkers.
    Benberin V, Bektayeva R, Karabayeva R, Lebedev A, Akemeyeva K, Paloheimo L, Syrjänen K.
    Anticancer Res; 2013 Oct 31; 33(10):4595-602. PubMed ID: 24123036
    [Abstract] [Full Text] [Related]

  • 9. [The effects of eradication therapy in patients with chronic atrophic gastritis and seropositivity for anti-HP antibodies and histological negativity for Helicobacter pylori].
    Leri O, Mastropasqua M, Scopelliti G, Grasso E, Losi T, Iadicicco A, Perinelli P.
    Clin Ter; 1999 Oct 31; 150(5):343-6. PubMed ID: 10687264
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacterpylori antibodies in the management of dyspeptic patients in primary care.
    Germaná B, Di Mario F, Cavallaro LG, Moussa AM, Lecis P, Liatoupolou S, Comparato G, Carloni C, Bertiato G, Battiestel M, Papa N, Aragona G, Cavestro GM, Iori V, Merli R, Bertolini S, Caruana P, Franzé A.
    Dig Liver Dis; 2005 Jul 31; 37(7):501-8. PubMed ID: 15975537
    [Abstract] [Full Text] [Related]

  • 13. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study.
    Sipponen P, Ranta P, Helske T, Kääriäinen I, Mäki T, Linnala A, Suovaniemi O, Alanko A, Härkönen M.
    Scand J Gastroenterol; 2002 Jul 31; 37(7):785-91. PubMed ID: 12190091
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis.
    Koike T, Ohara S, Sekine H, Iijima K, Kato K, Shimosegawa T, Toyota T.
    Am J Gastroenterol; 1999 Dec 31; 94(12):3468-72. PubMed ID: 10606305
    [Abstract] [Full Text] [Related]

  • 17. Serum pepsinogen concentration as a marker of Helicobacter pyloriinfection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels.
    Kiyohira K, Yoshihara M, Ito M, Haruma K, Tanaka S, Chayama K.
    J Gastroenterol; 2003 Dec 31; 38(4):332-8. PubMed ID: 12743772
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.